Your browser doesn't support javascript.
loading
Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine.
Zhang, Zhegang; Jiang, Zheng; Deng, Tao; Zhang, Jiayou; Liu, Bo; Liu, Jing; Qiu, Ran; Zhang, Qingmei; Li, Xuedan; Nian, Xuanxuan; Hong, Yue; Li, Fang; Peng, Feixia; Zhao, Wei; Xia, Zhiwu; Huang, Shihe; Liang, Shuyan; Chen, Jinhua; Li, Changgui; Yang, Xiaoming.
Afiliação
  • Zhang Z; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Jiang Z; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Deng T; National Institute of Food and Drug Control, Beijing, 100050, China.
  • Zhang J; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Liu B; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Liu J; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Qiu R; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Zhang Q; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Li X; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Nian X; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Hong Y; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Li F; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Peng F; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Zhao W; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Xia Z; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Huang S; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Liang S; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Chen J; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
  • Li C; National Engineering Technology Research Center of Combination Vaccines, China National Biotec Group, Wuhan, 430207, China.
  • Yang X; Viral Vaccines Research and Development Department 2, Wuhan Institute of Biological Products Co., LTD, Wuhan, 430207, China.
Open Life Sci ; 17(1): 1282-1295, 2022.
Article em En | MEDLINE | ID: mdl-36249527
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Open Life Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Open Life Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China